Inhibitory Antibodies
-
F1918 Anti-Amyloid Beta Antibody (Merck patent anti-Amyloid Beta)Summary: Anti-Amyloid Beta Antibody (Merck patent anti-Amyloid Beta) -
F1917 Anti-Amyloid Beta Antibody (Kumamoto U. patent anti-Amyloid Beta)Summary: Anti-Amyloid Beta Antibody (Kumamoto U. patent anti-Amyloid Beta) -
F1916 Anti-Amyloid Beta Antibody (Georgetown U. patent anti-Amyloid Beta)Summary: Anti-Amyloid Beta Antibody (Georgetown U. patent anti-Amyloid Beta) -
F1915 Anti-Amyloid Beta Antibody (Amgen patent anti-beta amyloid)Summary: Anti-Amyloid Beta Antibody (Amgen patent anti-beta amyloid) -
F1914 Anti-AMHR2 Antibody (Murlentamab-MMAE)Summary: Anti-AMHR2 Antibody (Murlentamab-MMAE) -
F1913 Anti-ALP Antibody (Seagen Patent Anti-Alpp)Summary: Anti-ALP Antibody (Seagen Patent Anti-Alpp) -
F1912 Anti-ALCAM/CD166 Antibody (Praluzatamab-MMAE)Summary: Anti-ALCAM/CD166 Antibody (Praluzatamab-MMAE) -
F1911 Anti-ACVR2B Antibody (Acceleron patent anti-ActRIIB)Summary: Anti-ACVR2B Antibody (Acceleron patent anti-ActRIIB) -
F1910 Anti-Abm Antibody (IgG4+Kappa Isotype Control)Summary: Anti-Abm Antibody (IgG4+Kappa Isotype Control) -
F1909 Anti-Abm Antibody (IgG1+Kappa Isotype Control)Summary: Anti-Abm Antibody (IgG1+Kappa Isotype Control)